Literature DB >> 12963351

Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase.

John Kenny1, Yuhne Bao, Brian Hamm, Lynn Taylor, Ann Toth, Brian Wagers, Norman P Curthoys.   

Abstract

The human gene that encodes the kidney-type glutaminase (KGA) spans 84-kb, contains 19 exons, and encodes two alternatively spliced mRNAs. Various segments of the rat KGA cDNA were PCR amplified and cloned into a bacterial expression vector to determine whether the N- and C- terminal ends of the glutaminase protein were essential for activity. A recombinant glutaminase, lacking the coding sequence contained in exon 1, was found to be fully active. In contrast, proteins that lacked sequences from exons 1 and 2 and exons 1-3 were inactive. An additional construct that corresponded to the sequence encoded by exons 2-14 also retained full activity. Both of the fully active, truncated proteins were purified to apparent homogeneity using an incorporated N-terminal His(6)-tag and Ni(2+)-affinity chromatography. The K(M) values for glutamine of the native and recombinant forms of glutaminase were nearly identical. However, the two truncated forms of the glutaminase exhibit the characteristic phosphate activation profile only when dialyzed into a buffer lacking phosphate. Dialysis versus 10mM Tris-phosphate was sufficient to form an active tetramer. Thus, the deleted N-terminal sequence may contribute to the phosphate-dependent oligomerization and activation of the native glutaminase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963351     DOI: 10.1016/s1046-5928(03)00161-x

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  30 in total

1.  Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells.

Authors:  Clint A Stalnecker; Scott M Ulrich; Yunxing Li; Sekar Ramachandran; Mary Kate McBrayer; Ralph J DeBerardinis; Richard A Cerione; Jon W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-29       Impact factor: 11.205

2.  Characterization of salt-tolerant glutaminase from Stenotrophomonas maltophilia NYW-81 and its application in Japanese soy sauce fermentation.

Authors:  Mamoru Wakayama; Tomohiro Yamagata; Aki Kamemura; Nitaya Bootim; Shigekazu Yano; Takashi Tachiki; Kazuaki Yoshimune; Mitsuaki Moriguchi
Journal:  J Ind Microbiol Biotechnol       Date:  2005-11-03       Impact factor: 3.346

3.  Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.

Authors:  Larissa Menezes Dos Reis; Douglas Adamoski; Rodolpho Ornitz Oliveira Souza; Carolline Fernanda Rodrigues Ascenção; Krishina Ratna Sousa de Oliveira; Felipe Corrêa-da-Silva; Fábio Malta de Sá Patroni; Marília Meira Dias; Sílvio Roberto Consonni; Pedro Manoel Mendes de Moraes-Vieira; Ariel Mariano Silber; Sandra Martha Gomes Dias
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

4.  Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.

Authors:  Jian-Bin Wang; Jon W Erickson; Reina Fuji; Sekar Ramachandran; Ping Gao; Ramani Dinavahi; Kristin F Wilson; Andre L B Ambrosio; Sandra M G Dias; Chi V Dang; Richard A Cerione
Journal:  Cancer Cell       Date:  2010-09-14       Impact factor: 31.743

5.  Functional and structural characterization of four glutaminases from Escherichia coli and Bacillus subtilis.

Authors:  Greg Brown; Alex Singer; Michael Proudfoot; Tatiana Skarina; Youngchang Kim; Changsoo Chang; Irina Dementieva; Ekaterina Kuznetsova; Claudio F Gonzalez; Andrzej Joachimiak; Alexei Savchenko; Alexander F Yakunin
Journal:  Biochemistry       Date:  2008-05-06       Impact factor: 3.162

6.  Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice.

Authors:  Ranjit Kumar Mehta; Shikha Verma; Rashmirekha Pati; Mitali Sengupta; Biswajit Khatua; Rabindra Kumar Jena; Sudha Sethy; Santosh K Kar; Chitra Mandal; Klaus H Roehm; Avinash Sonawane
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

7.  Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors.

Authors:  Krupa Shukla; Dana V Ferraris; Ajit G Thomas; Marigo Stathis; Bridget Duvall; Greg Delahanty; Jesse Alt; Rana Rais; Camilo Rojas; Ping Gao; Yan Xiang; Chi V Dang; Barbara S Slusher; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2012-11-30       Impact factor: 7.446

8.  Sulforaphane Prevents Methylmercury-Induced Oxidative Damage and Excitotoxicity Through Activation of the Nrf2-ARE Pathway.

Authors:  Shu Feng; Zhaofa Xu; Fei Wang; Tianyao Yang; Wei Liu; Yu Deng; Bin Xu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 9.  Rho GTPases and their roles in cancer metabolism.

Authors:  Kristin F Wilson; Jon W Erickson; Marc A Antonyak; Richard A Cerione
Journal:  Trends Mol Med       Date:  2012-12-05       Impact factor: 11.951

10.  A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor.

Authors:  Adnan Elhammali; Joseph E Ippolito; Lynne Collins; Jan Crowley; Jayne Marasa; David Piwnica-Worms
Journal:  Cancer Discov       Date:  2014-04-16       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.